Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

MR Liebowitz, AL Manley… - … medical research and …, 2008 - Taylor & Francis
Objective: To assess the efficacy, safety, and tolerability of 50-and 100-mg/day doses of
desvenlafaxine (administered as desvenlafaxine succinate), a serotonin-norepinephrine …
被引用次数：178 相关文章

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

MR Liebowitz, AL Manley, SK Padmanabhan… - 2008 - pubmed.ncbi.nlm.nih.gov
Objective To assess the efficacy, safety, and tolerability of 50-and 100-mg/day doses of
desvenlafaxine (administered as desvenlafaxine succinate), a serotonin-norepinephrine …

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder

MR Liebowitz, AL Manley… - Current Medical …, 2008 - search.proquest.com
OBJECTIVE: To assess the efficacy, safety, and tolerability of 50-and 100-mg/day doses of
desvenlafaxine (administered as desvenlafaxine succinate), a serotonin-norepinephrine …

Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients with major depressive disorder.

MR Liebowitz, AL Manley… - Current Medical …, 2008 - europepmc.org
Objective To assess the efficacy, safety, and tolerability of 50-and 100-mg/day doses of
desvenlafaxine (administered as desvenlafaxine succinate), a serotonin-norepinephrine …